Singapore Exchange (SGX, SGX:S68)’s 1H22 PAT missed MIBG expectations, but was in-line with Street.
SGX’s derivatives, FX and commodities segments are delivering growth. Rising global uncertainty from rate hikes, Chinese domestic policy, inflation as well as regional re-opening should drive upside to volumes for SGX’s risk management solutions going forward, in our view.
Singapore’s increased relevance as a value-oriented investment destination should drive an inflection in performance, we believe.
Underlying Business Delivering Growth
SGX missed largely on weaker than expected treasury income. This typically contributes around 9% of revenues, but in 1H22, it was 3%. Lower yields were to blame and re-pricing could take 6-9 months despite higher rate expectations going forward, according to Management.
On the other hand, we note higher volumes in fixed income, FX, commodity derivatives as well as equity derivatives. Despite a competing product on the China A50 index futures introduced by HKEX (388 HK) in Oct, income here expanded 10% Oct-Dec, according to Management, signifying the Group’s strong risk management offering.
Volatility, Re-opening Positive Catalysts
Increased uncertainty from monetary tightening, the execution of China’s common fees going forward, in our view.
Lower Target Price for SGX But Upgrade to BUY
Weaker treasury income and lower equity clearing fees (-2% y-o-y from higher market maker participation), sees us reducing FY22-24E PAT trade at 30x FY22E P/E, still 9% cheaper than ASX, which is another largely value-oriented exchange.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....